Digestive Disease Week
Login
Cart
Support
Search
Categories
  • Tracks

Tags
  • AGA

  • ASGE

  • DDW

  • SSAT

  • AASLD

  • AGA/AASLD

  • Education and Training

  • Society

  • OTHER

  1. Browse Content
  2. Tracks
  3. AGA

AGA

Back
  • Thumbnail for A PROSPECTIVE, MULTI-INSTITUTIONAL STUDY REVEALS THE COMBINATION OF RNA ANALYSIS WITH DNA-BASED NEXT-GENERATION SEQUENCING (NGS) IMPROVES THE PREOPERATIVE CLASSIFICATION OF PANCREATIC CYSTS AND IDENTIFICATION OF ADVANCED NEOPLASIA

    A PROSPECTIVE, MULTI-INSTITUTIONAL STUDY REVEALS THE COMBINATION OF RNA ANALYSIS WITH DNA-BASED NEXT-GENERATION SEQUENCING (NGS) IMPROVES THE PREOPERATIVE CLASSIFICATION OF PANCREATIC CYSTS AND IDENTIFICATION OF ADVANCED NEOPLASIA

    Date
    May 21, 2024
    BACKGROUND: As outlined by the Kyoto guidelines, targeted DNA-based NGS of pancreatic cyst fluid (PCF) is an important adjunct to the evaluation of pancreatic cyst patients…

    Presenter

    Speaker Image for Elham Afghani
    Elham Afghani

    Speakers

    Speaker Image for Anne Marie O'Broin-Lennon
    Anne Marie O'Broin-Lennon
    Speaker Image for Kevin Mcgrath
    Kevin Mcgrath
    Speaker Image for Tarek Sawas
    Tarek Sawas
    Mayo Clinic
    Speaker Image for Nisa Kubiliun
    Nisa Kubiliun
    Speaker Image for Randall Brand
    Randall Brand
    University of Pittsburgh
    Speaker Image for Walter Park
    Walter Park
    Stanford University
    Speaker Image for Patrick Pfau
    Patrick Pfau
    University of Wisconsin
    Speaker Image for John Dewitt
    John M. Dewitt
    Indiana University Health Medical Center
    Speaker Image for Shaffer Mok
    Shaffer Mok
    Speaker Image for Michael Wallace
    Michael Wallace
    Mayo Clinic
    Speaker Image for Shyam Thakkar
    Shyam Thakkar
    Speaker Image for Tiffany Chua
    Tiffany Chua
    University of Florida
    Speaker Image for Yasser Bhat
    Yasser Bhat
    Speaker Image for Nikhil Thiruvengadam
    Nikhil Thiruvengadam
    Speaker Image for Tamas Gonda
    Tamas Gonda
    Speaker Image for Wasseem Skef
    Wasseem Skef
    Speaker Image for Mustafa Arain
    Mustafa Arain
    AdventHealth Orlando
    Speaker Image for Andres Gelrud
    Andres Gelrud
    Speaker Image for Anjuli Luthra
    Anjuli Luthra
    Speaker Image for Joanna Law
    Joanna Law
    Speaker Image for Asif Khalid
    Asif Khalid
    Speaker Image for Rohit Das
    Rohit Das
    Speaker Image for Kenneth Fasanella
    Kenneth Fasanella
    Speaker Image for Harkirat Singh
    Harkirat Singh
    Speaker Image for Stephanie Romutis
    Stephanie Romutis
    Speaker Image for Adam Slivka
    Adam Slivka
    Speaker Image for Abigail Wald
    Abigail Wald
    Speaker Image for Marina Nikiforova
    Marina Nikiforova
    Speaker Image for Aatur Singhi
    Aatur Singhi
  • Thumbnail for PANEL DISCUSSION

    PANEL DISCUSSION

    Date
    May 20, 2024

    Presenters

    Speaker Image for Virginie Aubert-Mansuy
    Virginie Aubert-Mansuy
    Speaker Image for Mohamad Mokadem
    Mohamad Mokadem
    University of Iowa
    Speaker Image for Tiffany Freeney Wright
    Tiffany Freeney Wright
    Speaker Image for Yasutada Akiba
    Yasutada Akiba
  • Thumbnail for CLOSTRIDIOIDES DIFFICILE INFECTION INDUCES A PRO-STEATOTIC AND PRO-INFLAMMATORY METABOLIC STATE IN LIVER

    CLOSTRIDIOIDES DIFFICILE INFECTION INDUCES A PRO-STEATOTIC AND PRO-INFLAMMATORY METABOLIC STATE IN LIVER

    Date
    May 18, 2024
    BACKGROUND: Recent studies suggest links between _Clostridioides difficile_ infection (CDI) and liver disorders, with non-alcoholic fatty liver disease (NAFLD) increasing CDI risk and CDI exacerbating the progression and prognosis of liver cirrhosis. Moreover, gut dysbiosis, often leading to _C…

    Presenter

    Speaker Image for Farnaz Yousefi
    Farnaz Yousefi

    Speaker

    Speaker Image for Shankumar Mooyottu
    Shankumar Mooyottu
  • Thumbnail for INTRO

    INTRO

    Date
    May 20, 2024

    Presenter

    Speaker Image for George Verne
    George Verne
  • Thumbnail for CASE PRESENTATIONS

    CASE PRESENTATIONS

    Date
    May 21, 2024

    Presenter

    Speaker Image for Emily Rubin
    Emily Rubin
  • Thumbnail for WEIGHT INCLUSIVITY: A HEALTH SYSTEMS APPROACH

    WEIGHT INCLUSIVITY: A HEALTH SYSTEMS APPROACH

    Date
    May 21, 2024

    Presenter

    Speaker Image for Colleen Tewksbury
    Colleen Tewksbury
  • Thumbnail for STATE-OF-THE-ART LECTURE: TARGETING THE MICROBIOME TO PROMOTE HEALTH AND END CANCER

    STATE-OF-THE-ART LECTURE: TARGETING THE MICROBIOME TO PROMOTE HEALTH AND END CANCER

    Date
    May 21, 2024

    Presenter

    Speaker Image for Jennifer Wargo
    Jennifer Wargo
  • Thumbnail for INTRODUCTION

    INTRODUCTION

    Date
    May 21, 2024

    Presenter

    Speaker Image for Gary Wu
    Gary Wu
    University of Pennsylvania
  • Thumbnail for Gail Hecht, MD, and David Hecht, MD, Distinguished Microbiome Lecture

    Gail Hecht, MD, and David Hecht, MD, Distinguished Microbiome Lecture

    Date
    May 21, 2024
    SOCIETY: AGA

    Moderators

    Speaker Image for Suzanne Devkota
    Suzanne Devkota
    Cedars-Sinai Medical Center
    Speaker Image for Bryson Katona
    Bryson Katona
    University of Pennsylvania
  • Thumbnail for RELEASE OF RISK EVALUATION AND MITIGATION STRATEGIES (REMS) FOR LOTRONEX (ALOSETRON HYDROCHLORIDE)

    RELEASE OF RISK EVALUATION AND MITIGATION STRATEGIES (REMS) FOR LOTRONEX (ALOSETRON HYDROCHLORIDE)

    Date
    May 20, 2024

    Presenter

    Speaker Image for Joyce Korvick
    Joyce Korvick
  • Thumbnail for FDA REVIEW OF VELSIPITY (ETRASIMOD) FOR ULCERATIVE COLITIS

    FDA REVIEW OF VELSIPITY (ETRASIMOD) FOR ULCERATIVE COLITIS

    Date
    May 20, 2024

    Presenter

    Speaker Image for Matthew Kowalik
    Matthew Kowalik
  • Thumbnail for FDA REVIEW OF VOQUEZNA (VONOPRAZAN) FOR EROSIVE ESOPHAGITIS

    FDA REVIEW OF VOQUEZNA (VONOPRAZAN) FOR EROSIVE ESOPHAGITIS

    Date
    May 20, 2024

    Presenter

    Speaker Image for Joette Meyer
    Joette Meyer
  • Thumbnail for FDA REVIEW OF EOHILIA (BUDESONIDE ORAL SOLUTION) FOR EOSINOPHILIC ESOPHAGITIS

    FDA REVIEW OF EOHILIA (BUDESONIDE ORAL SOLUTION) FOR EOSINOPHILIC ESOPHAGITIS

    Date
    May 20, 2024

    Presenter

    Speaker Image for Erica Lyons
    Erica Lyons
  • Thumbnail for INTRODUCTION

    INTRODUCTION

    Date
    May 20, 2024

    Presenter

    Speaker Image for Jessica Lee
    Jessica Lee
  • Thumbnail for FDA Town Hall

    FDA Town Hall

    Date
    May 20, 2024
    SOCIETY: AGA The AGA-FDA Town Hall provides health care professionals, clinical trial investigators, and other interested stakeholders an opportunity to hear directly from FDA representatives about the agency's thinking behind recent approvals, safety signals, guidance documents, and boxed warnings…

    Moderators

    Speaker Image for Scott Harris
    Scott Harris
    Middleburg Consultants
    Speaker Image for Colin Howden
    Colin Howden
    University of Tennessee Health Science Center
  • Thumbnail for WEIGHT GAIN IS ASSOCIATED WITH DECREASED TREATMENT RESPONSE TO DIET THERAPY IN ADULTS WITH EOSINOPHILIC ESOPHAGITIS

    WEIGHT GAIN IS ASSOCIATED WITH DECREASED TREATMENT RESPONSE TO DIET THERAPY IN ADULTS WITH EOSINOPHILIC ESOPHAGITIS

    Date
    May 21, 2024
    BACKGROUND: Dietary therapy is an effective treatment for eosinophilic esophagitis (EoE), however, the influence of body mass index (BMI) on treatment response is unclear…

    Presenter

    Speaker Image for Stephanie Borinsky
    Stephanie Borinsky

    Speakers

    Speaker Image for Sean LaFata
    Sean LaFata
    Speaker Image for Timothy Gee
    Timothy Gee
    Speaker Image for Hannah Thel
    Hannah Thel
    Speaker Image for Brenderia Cameron
    Brenderia Cameron
    Speaker Image for Angela Xue
    Angela Xue
    Speaker Image for Akshatha Kiran
    Akshatha Kiran
    Speaker Image for Adolfo Ocampo
    Adolfo Ocampo
    Speaker Image for Justin McCallen
    Justin McCallen
    Speaker Image for Christopher Lee
    Christopher Lee
    Speaker Image for Walker Redd
    Walker Redd
    Speaker Image for Trevor Barlowe
    Trevor Barlowe
    Speaker Image for Rayan Kaakati
    Rayan Kaakati
    Speaker Image for Cary Cotton
    Cary Cotton
    Speaker Image for Swathi Eluri
    Swathi Eluri
    Speaker Image for Craig Reed
    Craig Reed
    Speaker Image for Evan Dellon
    Evan Dellon
    University of North Carolina School of Medicine
  • Thumbnail for DIFFERENTIAL GASTRIC MOTILITY, GUT HORMONE, AND APPETITE REGULATION IN HEALTHY AND OBESE SUBJECTS

    DIFFERENTIAL GASTRIC MOTILITY, GUT HORMONE, AND APPETITE REGULATION IN HEALTHY AND OBESE SUBJECTS

    Date
    May 21, 2024
    INTRODUCTION: The novel hybrid GLP-1/GIP receptor agonist concept, with efficacy surpassing GLP-1 agonist medication, is promising for treatment of obesity. Nevertheless, its mechanism of action is not fully understood…

    Presenter

    Speaker Image for Darius Javidi
    Darius Javidi

    Speakers

    Speaker Image for Dominic-Luc Webb
    Dominic-Luc Webb
    Speaker Image for Per Hellström
    Per Hellström
  • Thumbnail for METABOLIC OUTCOMES AND MECHANISMS OF ACTION FOR DUODENAL BI-PARTITION IN THE TREATMENT OF OBESITY AND TYPE 2 DIABETES MELLITUS: A 4-YEAR PROSPECTIVE OBSERVATIONAL STUDY

    METABOLIC OUTCOMES AND MECHANISMS OF ACTION FOR DUODENAL BI-PARTITION IN THE TREATMENT OF OBESITY AND TYPE 2 DIABETES MELLITUS: A 4-YEAR PROSPECTIVE OBSERVATIONAL STUDY

    Date
    May 21, 2024
    INTRODUCTION: Roux-en-Y gastric bypass (RYGB) is an effective treatment for patients suffering from obesity and concomitant type 2 diabetes mellitus (T2DM). Nevertheless, less than 2% of eligible patients choose to undergo the surgery…

    Presenter

    Speaker Image for Pichamol Jirapinyo
    Pichamol Jirapinyo

    Speakers

    Speaker Image for Francisco Schlottmann
    Francisco Schlottmann
    Speaker Image for David Lautz
    David Lautz
    Speaker Image for Marvin Ryou
    Marvin Ryou
    Speaker Image for Christopher Thompson
    Christopher C. Thompson
    Brigham and Women's Hospital
    Speaker Image for Rudolf Buxhoeveden
    Rudolf Buxhoeveden
  • Thumbnail for DOES THE MEDITERRANEAN DIET HAVE SIMILAR EFFICACY AS A LOW FODMAP DIET IN IRRITABLE BOWEL SYNDROME? RESULTS FROM A PILOT RANDOMIZED CONTROLLED TRIAL

    DOES THE MEDITERRANEAN DIET HAVE SIMILAR EFFICACY AS A LOW FODMAP DIET IN IRRITABLE BOWEL SYNDROME? RESULTS FROM A PILOT RANDOMIZED CONTROLLED TRIAL

    Date
    May 21, 2024
    INTRODUCTION: A diet low in FODMAPs (LFD) is only effective in 50-60% of patients with irritable bowel syndrome (IBS) and is restrictive, time-consuming, and carries the risk of nutritional deficiencies. Therefore, there is a need for novel dietary therapies for IBS…

    Presenter

    Speaker Image for Prashant Singh
    Prashant Singh
    University of Michigan

    Speakers

    Speaker Image for Sofia Iram
    Sofia Iram
    Speaker Image for Samuel Chey
    Samuel Chey
    Speaker Image for Samara Rifkin
    Samara Rifkin
    Speaker Image for Gregory Dean
    Gregory Dean
    Speaker Image for Asaf Kraus
    Asaf Kraus
    Speaker Image for Christine Lothen-Kline
    Christine Lothen-Kline
    Speaker Image for Jane Muir
    Jane Muir
    Speaker Image for Shanti Eswaran
    Shanti Eswaran
    University of Michigan
    Speaker Image for William Chey
    William D. Chey
    Michigan Medicine
  • Thumbnail for THE INFLUENCE OF BODY WEIGHT ON GASTROINTESTINAL (GI) GAS PRODUCTION

    THE INFLUENCE OF BODY WEIGHT ON GASTROINTESTINAL (GI) GAS PRODUCTION

    Date
    May 21, 2024
    INTRODUCTION: Body weight influences the GI response to meals. Studies have demonstrated post-prandial GI symptoms and dysfunction at the extremes of the BMI scale. More specifically, underweight individuals (BMI < 18…

    Speakers

    Speaker Image for Mythili Pathipati
    Mythili Pathipati
    Speaker Image for Robert Burke
    Robert Burke
    Speaker Image for Claire Shortt
    Claire Shortt
    Speaker Image for Aonghus Shortt
    Aonghus Shortt

    Presenter

    Speaker Image for Kyle Staller
    Kyle Staller
    Massachusetts General Hospital
  • Thumbnail for SATIATION TESTING AND A SURROGATE MACHINE-LEARNING ASSISTED GENE RISK SCORE BIOMARKER PREDICT DIFFERENTIAL RESPONSES TO LIFESTYLE INTERVENTIONS: A POST-HOC ANALYSIS OF A SINGLE CENTER, NON-RANDOMIZED CLINICAL TRIAL

    SATIATION TESTING AND A SURROGATE MACHINE-LEARNING ASSISTED GENE RISK SCORE BIOMARKER PREDICT DIFFERENTIAL RESPONSES TO LIFESTYLE INTERVENTIONS: A POST-HOC ANALYSIS OF A SINGLE CENTER, NON-RANDOMIZED CLINICAL TRIAL

    Date
    May 21, 2024
    INTRODUCTION: A phenotype-tailored lifestyle intervention (PLI) has shown superior outcomes when compared to a standard lifestyle intervention (SLI) in a 12-week trial (PMID: 37007741). However, phenotype testing for obesity is time-consuming, expensive, and not widely accessible…

    Presenter

    Speaker Image for Diego Anazco
    Diego Anazco

    Speakers

    Speaker Image for Lizeth Cifuentes
    Lizeth Cifuentes
    Speaker Image for Sima Fansa
    Sima Fansa
    Speaker Image for Wissam Ghusn
    Wissam Ghusn
    Speaker Image for Alejandro Campos
    Alejandro Campos
    Speaker Image for Elif Tama
    Elif Tama
    Speaker Image for Khushboo Gala
    Khushboo Gala
    Speaker Image for Jessica Stutzman
    Jessica Stutzman
    Speaker Image for Megan Schaefer
    Megan Schaefer
    Speaker Image for Donald Hensrud
    Donald Hensrud
    Speaker Image for Maria Hurtado
    Maria Hurtado
    Speaker Image for Andres Acosta
    Andres Acosta
    Mayo Foundation for Medical Education and Research
  • Thumbnail for EFFICACY OF STRUCTURAL INDIVIDUAL LOW FODMAP DIETARY ADVICE (SILFD) FOR GASTROESOPHAGEAL REFLUX DISEASE (GERD) : A RANDOMIZED TRIAL

    EFFICACY OF STRUCTURAL INDIVIDUAL LOW FODMAP DIETARY ADVICE (SILFD) FOR GASTROESOPHAGEAL REFLUX DISEASE (GERD) : A RANDOMIZED TRIAL

    Date
    May 21, 2024
    Previous studies showed that high FODMAP meals induced a higher frequency of transient lower esophageal sphincter relaxation and reflux symptoms in patients with overlapping IBS and GERD…

    Presenter

    Speaker Image for Kandechpong Sritunyarat
    Kandechpong Sritunyarat

    Speakers

    Speaker Image for Tanisa Patcharatrakul
    Tanisa Patcharatrakul
    Speaker Image for Jarongkorn Sirimongkolkasem
    Jarongkorn Sirimongkolkasem
    Speaker Image for Pakkapon Rattanachaisit
    Pakkapon Rattanachaisit
    Speaker Image for Sutep Gonlachanvit
    Sutep Gonlachanvit
  • Thumbnail for OMN Premier Abstracts

    OMN Premier Abstracts

    Date
    May 21, 2024
    SOCIETY: AGA

    Moderators

    Speaker Image for Andres Acosta
    Andres Acosta
    Mayo Foundation for Medical Education and Research
    Speaker Image for Rohit Kohli
    Rohit Kohli
    Children's Los Angeles
  • Thumbnail for WHO SUFFERS FROM OCCASIONAL CONSTIPATION? CLINICAL-PSYCHOLOGICAL CHARACTERISTICS AND ASSOCIATED FACTORS IN AN OPEN POPULATION IN MEXICO.

    WHO SUFFERS FROM OCCASIONAL CONSTIPATION? CLINICAL-PSYCHOLOGICAL CHARACTERISTICS AND ASSOCIATED FACTORS IN AN OPEN POPULATION IN MEXICO.

    Date
    May 20, 2024
    BACKGROUND: In terms of temporality, constipation is categorized as either acute or chronic. When chronic constipation occurs without alarm features and secondary causes, it is labeled as functional chronic constipation (FCC, Rome IV)…

    Presenter

    Speaker Image for Jose Maria Remes-Troche
    Jose Maria Remes-Troche

    Speakers

    Speaker Image for Mariali Palacios-Cruz
    Mariali Palacios-Cruz
    Speaker Image for Bryan Adrian Priego-Parra
    Bryan Adrian Priego-Parra
    Speaker Image for Karla Garcia Zermeño
    Karla Garcia Zermeño
    Speaker Image for Luis Valdovinos-Garcia
    Luis Valdovinos-Garcia
    Speaker Image for Francisco Felix Tellez
    Francisco Felix Tellez
    Speaker Image for Jose Antonio Velarde Ruiz Velasco
    Jose Antonio Velarde Ruiz Velasco
    Speaker Image for Enrique Coss-Adame
    Enrique Coss-Adame
    Speaker Image for Ricardo Flores Rendon
    Ricardo Flores Rendon
    Speaker Image for Mercedes Amieva-Balmori
    Mercedes Amieva-Balmori
  • …
Privacy Center

Copyright © 2025 Digestive Disease Week
Powered by Conexiant DXP